Skip to content

Pfizer PFE Deferred Revenue

Discontinued — last reported Q4 '25

Deferred Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$69.2M-14.7%
Moderna logo
ModernaMRNA
$102M-18.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$0-100%
Exelixis logo
ExelixisEXEL

Segments

By product

See full
Comirnaty$2.1B-30.0%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$134.91B-1.0%
Enterprise value$197.57B+0.7%
P/E11.1×
P/S2.1×-0.1×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's deferred revenue?
Pfizer (PFE) reported deferred revenue of $784M in Q4 2025.
How has Pfizer's deferred revenue changed year-over-year?
Pfizer's deferred revenue decreased by 48.1% year-over-year, from $1.51B to $784M.
What is the long-term trend for Pfizer's deferred revenue?
Over 5 years (2020 to 2025), Pfizer's deferred revenue has grown at a -6.8% compound annual growth rate (CAGR), from $1.11B to $784M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.